Cedars-Sinai Intellectual Property Company is partnering with Oxford Science Enterprises (OSE), through a major co-investment initiative. The partnership with OSE, an independent investment company launched as a joint venture with the University of Oxford, will include the ability to co-build and co-invest in future health-tech startups coming out of Oxford.